Discontinuation report HP-PAC
Report ID | 118321 |
Drug Identification Number | 02238525 |
Brand name | HP-PAC |
Common or Proper name | AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN |
Company Name | TAKEDA PHARMACEUTICALS AMERICA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LANSOPRAZOLE AMOXICILLIN CLARITHROMYCIN |
Strength(s) | 30MG 500MG 500MG |
Dosage form(s) | KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | HP PAC 7 DAY THERAPY |
ATC code | A02BD |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-03-08 |
Remaining supply date | 2020-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Product Expired June 30, 2020. No remaining supply. |
Company comments | Product discontinued for business reason. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 95 HAYDEN AVENUE LEXINGTON, MASSACHUSETTS UNITED STATES 02421 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-03-09 | French | Compare |
v9 | 2021-03-09 | English | Compare |
v8 | 2020-06-18 | English | Compare |
v7 | 2020-06-18 | English | Compare |
v6 | 2020-06-18 | English | Compare |
v5 | 2020-06-18 | English | Compare |
v4 | 2020-06-18 | English | Compare |
v3 | 2020-06-18 | English | Compare |
v2 | 2020-06-18 | English | Compare |
v1 | 2020-06-18 | English | Compare |
Showing 1 to 10 of 10